187 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
for the additional investment.
On April 3, Ligand announced the creation of Pelthos Therapeutics under the leadership of Scott Plesha as Chief Executive
8-K
b4uf3e
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
EX-99.1
4vr tixwzmnmnfer
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
y5ccl0d56 doj
21 Jun 22
Regulation FD Disclosure
6:19am
425
EX-99.3
0llvsu9bf
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
n4dapwd24ck
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
nzx1juf78k9 dg1kxail
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.3
lp22w x1pw
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
ok5y4ecrohxtehwg2ye3
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
4d72gm1c9c2sg9y1
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm